⌘K
Loading ticker…
As of 2026-08-24, Passage Bio, Inc. Common Stock (PASG) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 2.91×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
PASG is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.1% / -41.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
PASG is held by 2 ETFs as of Apr 2026. Top owner: DCOR at 0.00% weight, $6K notional.
Held by 4 ETFs · $905K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DCOR | 0.00% | $6K | — |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $4K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PASG Jan avg: 0.82% median: 0.22% win: 50% σ: 4.29% n: 4 2022-04-12 → 2026-07-31 | PASG Feb avg: 6.69% median: -13.53% win: 25% σ: 45.37% n: 4 2022-04-12 → 2026-07-31 | PASG Mar avg: -22.24% median: -21.59% win: 0% σ: 7.36% n: 4 2022-04-12 → 2026-07-31 | PASG Apr avg: -15.50% median: -7.67% win: 20% σ: 20.59% n: 5 2022-04-12 → 2026-07-31 | PASG May avg: 3.77% median: -7.69% win: 40% σ: 19.42% n: 5 2022-04-12 → 2026-07-31 | PASG Jun avg: -4.78% median: -8.25% win: 20% σ: 22.81% n: 5 2022-04-12 → 2026-07-31 | PASG Jul avg: -8.66% median: -8.40% win: 20% σ: 13.28% n: 5 2022-04-12 → 2026-07-31 | PASG Aug avg: -3.39% median: -1.67% win: 50% σ: 15.52% n: 4 2022-04-12 → 2026-07-31 (current) | PASG Sep avg: -10.33% median: -7.92% win: 25% σ: 21.86% n: 4 2022-04-12 → 2026-07-31 | PASG Oct avg: -5.41% median: -3.55% win: 0% σ: 4.57% n: 4 2022-04-12 → 2026-07-31 | PASG Nov avg: 24.33% median: 7.49% win: 50% σ: 40.29% n: 4 2022-04-12 → 2026-07-31 | PASG Dec avg: 14.24% median: 23.38% win: 75% σ: 46.83% n: 4 2022-04-12 → 2026-07-31 |